A regulatory view on adaptive/flexible clinical trial design.
about
The Potential of Adaptive Design in Animal StudiesApplication of routine electronic health record databases for pharmacogenetic researchAttitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) projectInterpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.Choosing inclusion criteria that minimize the time and cost of clinical trialsAdaptive trial designs.Neuroprotection in acute brain injury: an up-to-date review.Adaptive trial design: could we use this approach to improve clinical trials in the field of global health?An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) projectPopulation and target considerations for triple-negative breast cancer clinical trials.Innovative approaches in drug development.Adaptive seamless designs: selection and prospective testing of hypotheses.Systems pharmacology, pharmacogenetics, and clinical trial design in network medicineAdaptive designs in clinical trials.Bayesian adaptive clinical trials: a dream for statisticians only?Designing fecal microbiota transplant trials that account for differences in donor stool efficacy.An adaptive two-stage dose-response design method for establishing proof of conceptExact confidence bounds following adaptive group sequential tests.Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.Flexible design clinical trial methodology in regulatory applications.An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.A varying-stage adaptive phase II/III clinical trial design.On flexibility of adaptive designs and criteria for choosing a good one--a discussion of FDA draft guidance.Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov.Novel trial design: a report from the 19th frontiers symposium of ACCP.
P2860
Q26782470-F186CDA7-0537-4C30-9A2A-5D2A2DC01FDEQ26864747-00F2027A-33C5-46C3-AF1B-90F03EA22812Q27332279-75F30EB4-8305-4E12-9993-987DC88603B5Q30487266-F82EC284-1B8A-4C5A-924A-66F54F52A316Q34367570-8C92ED80-5E59-494B-96A7-198A7351A62FQ34977626-E5F7E386-D2C9-46D5-8124-84E77CCC1917Q35503413-C251722D-8CFE-4343-84A0-FF43641C6252Q35576121-52BF4B3E-F92B-47B7-96B2-C55AA9E646C5Q36570348-389183AC-23C3-45E3-9322-2ACE493C343FQ36914317-7B996995-59DE-4C71-98F9-A2248CFDFB5DQ36948313-F2E7DB35-8FA7-41CC-A1FB-C4FAAEBBF8CFQ37008670-F683CDB5-7AC7-4E82-933C-AA25E39591F5Q37199477-E45A6FC6-0783-45C2-83D5-7B0BF9FA9F48Q37876282-B39F460D-4E0C-4C45-A423-4B85A0B1C384Q39709250-DB4C0E65-BFAE-40C8-AAB1-5282B36B2CE3Q40339859-B6B1DBD0-EAEF-44B8-BA20-9B439FCB29C1Q41339618-90BB672D-94C7-4890-B6E9-1AF4F813724EQ43580763-2DBE3C03-2EF2-44D1-89EF-E1A8374D07A8Q43727354-C13B311B-F2EB-4796-9679-1E06D1EBA8C0Q43869804-67C0A21C-F6E8-4FAF-A651-E1F3CEDC7766Q44262116-8F480DB6-9AA5-49D9-B67C-8095DB2310D1Q44494327-E2D8EF02-D6CE-4872-973A-CC52CADA653CQ45328879-4FFA460B-6D52-4EB5-8341-3B2B6E75B28CQ50027402-88272606-ED70-499A-B319-289EF999B3FBQ51878138-D9412DAC-F37A-4855-8463-BB1E8D86AB5D
P2860
A regulatory view on adaptive/flexible clinical trial design.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A regulatory view on adaptive/flexible clinical trial design.
@ast
A regulatory view on adaptive/flexible clinical trial design.
@en
type
label
A regulatory view on adaptive/flexible clinical trial design.
@ast
A regulatory view on adaptive/flexible clinical trial design.
@en
prefLabel
A regulatory view on adaptive/flexible clinical trial design.
@ast
A regulatory view on adaptive/flexible clinical trial design.
@en
P2093
P356
P1433
P1476
A regulatory view on adaptive/flexible clinical trial design.
@en
P2093
H M James Hung
John Lawrence
Robert T O'Neill
Sue-Jane Wang
P304
P356
10.1002/BIMJ.200610229
P577
2006-08-01T00:00:00Z